Brokerages Set Cresco Labs Inc. (OTCMKTS:CRLBF) Target Price at $3.00

Cresco Labs Inc. (OTCMKTS:CRLBFGet Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $3.00.

A number of brokerages have commented on CRLBF. Cormark upgraded Cresco Labs from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 17th. Atb Cap Markets cut shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 9th.

Check Out Our Latest Analysis on CRLBF

Cresco Labs Stock Up 0.7 %

Shares of OTCMKTS CRLBF opened at $0.74 on Friday. Cresco Labs has a 52 week low of $0.69 and a 52 week high of $2.60. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The firm’s fifty day moving average is $0.86 and its 200 day moving average is $1.15. The company has a market cap of $361.22 million, a price-to-earnings ratio of -3.70 and a beta of 1.79.

Cresco Labs (OTCMKTS:CRLBFGet Free Report) last announced its earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, meeting analysts’ consensus estimates of ($0.01). The firm had revenue of $176.00 million for the quarter, compared to analysts’ expectations of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. On average, equities research analysts expect that Cresco Labs will post -0.2 earnings per share for the current year.

Cresco Labs Company Profile

(Get Free Report

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Read More

Analyst Recommendations for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.